Compile Data Set for Download or QSAR
Report error Found 53 Enz. Inhib. hit(s) with all data for entry = 60
TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109057BDBM109057(US9695205, 3)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109056BDBM109056(US9695205, 2)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109055BDBM109055(US9695205, 1)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109103BDBM109103(US9695205, 11)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109094BDBM109094(US9695205, 10)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109093BDBM109093(US9695205, 9)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109092BDBM109092(US9695205, 8)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109091BDBM109091(US9695205, 7)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109061BDBM109061(US9695205, 6)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109059BDBM109059(US9695205, 5)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109058BDBM109058(US9695205, 4)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109466BDBM109466(US9695205, 19)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109393BDBM109393(US9695205, 18)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109391BDBM109391(US9695205, 17)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109385BDBM109385(US9695205, 16)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109358BDBM109358(US9695205, 15)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109199BDBM109199(US9695205, 14)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109178BDBM109178(US9695205, 13)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109104BDBM109104(US9695205, 12)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 110040BDBM110040(US9695205, 27)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 110039BDBM110039(US9695205, 26)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109944BDBM109944(US9695205, 25)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109940BDBM109940(US9695205, 24)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109545BDBM109545(US9695205, 23)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109544BDBM109544(US9695205, 22)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109469BDBM109469(US9695205, 21)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 109468BDBM109468(US9695205, 20)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111053BDBM111053(US9695205, 35)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111052BDBM111052(US9695205, 34)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111050BDBM111050(US9695205, 33)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111049BDBM111049(US9695205, 32)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111048BDBM111048(US9695205, 31)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 110146BDBM110146(US9695205, 30)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 110043BDBM110043(US9695205, 29)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 110042BDBM110042(US9695205, 28)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111062BDBM111062(US9695205, 43)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111061BDBM111061(US9695205, 42)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111060BDBM111060(US9695205, 41)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111058BDBM111058(US9695205, 40)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111057BDBM111057(US9695205, 39)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111056BDBM111056(US9695205, 38)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111055BDBM111055(US9695205, 37)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111054BDBM111054(US9695205, 36)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111074BDBM111074(US9695205, 52)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111073BDBM111073(US9695205, 51)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111072BDBM111072(US9695205, 50)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111071BDBM111071(US9695205, 49)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111070BDBM111070(US9695205, 48)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111065BDBM111065(US9695205, 46)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 111064BDBM111064(US9695205, 45)
Affinity DataIC50: 1.00E+3nMpH: 7.5 T: 2°CAssay Description:Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
US Patent

Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: